Mr. Justin Hanka reports

MINDBIO TARGETS GLOBAL DIGITAL HEALTH DIAGNOSTICS MARKET WITH WORLD FIRST AI POWERED SPEECH ANALYTICS TECHNOLOGY

Mindbio Therapeutics Corp. is targeting the global digital health diagnostics market with a first-mover advantage in using speech as a diagnostic tool in drug and alcohol intoxication detection.

The voice is a powerful biomarker that can be used to assess and predict internal health and disease states. The company uses sophisticated machine learning models, developed during years of clinical trials, to analyze voice data and make predictions that are clinically meaningful and useful in a variety of consumer and enterprise situations.

The company has developed and commercialized a technology, activated by a simple analysis of the voice and powered by artificial intelligence to predict drug and alcohol intoxication. The company has amassed large amounts of data from drug and alcohol clinical trials and has developed proprietary algorithms as the basis for its prediction technologies with remarkable accuracy for the detection of alcohol and hallucinogenic drugs.

The company is currently showcasing its technology throughout the United States. The company's core technology can reliably predict intoxication with hallucinogens and alcohol by analyzing voice. The company plans to expand its algorithms to be able to detect other prohibited drugs that are difficult to detect particularly at scale and volume and require specialized equipment, with Mindbio's solution provided by a simple analysis of the voice.

The voice analytics solution being developed by Mindbio is a revolutionary innovation for intoxication detection in workplace environments, particularly where drug and alcohol testing is mandated by regulators, such as the mining industry, aviation and construction, and where high-volume testing at scale for a variety of drugs and alcohol presents major challenges for management, is time consuming and expensive.

In a world first, Mindbio has developed an AI model that uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The technology goes further to estimate actual blood alcohol concentration levels.

The company is developing an enterprise version and new platform level technology for health prediction using the human voice and is expanding its drug and alcohol intoxication technology for use in workplace environments, call centres, mental health and law enforcement, and the company hopes to make announcements about the progress of the new technology, new products and markets, and potential commercial applications, shortly.

The company's chief executive officer, Justin Hanka, said, "The digital health diagnostics market represents a significant opportunity for Mindbio to leverage its diagnostics technology with a first mover advantage in speech analytics for drug and alcohol intoxication detection".

About Mindbio Therapeutics Corp.

Mindbio Therapeutics is a biotechnology company headquartered in Vancouver that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.

We seek Safe Harbor.